I think the rounds would mean there is a net negative effect, but that may be mitigated somewhat - particularly when you consider the sub maximal effort put in for most of those rounds with his next fastest 100 3/10ths slower than his max and the 200 semi nearly a second slower than the final.
I’m not saying it made no difference, but I think with his reserve and the potentiation effect of the rounds negative is not as great as one may initially conclude.
At any rate, one of the biggest problems will be finding a meet that can afford Bolt. If he was asking for 250K before what will he be asking now? I just hope he doesn’t price himself out of the market. It may be worth his while taking a leaf from pharma pricing - charge what each market can afford rather than a fixed price for all. You have more experience in these matters than I, what are your thoughts on Bolts fees? With the number of races he has competed in, I can’t see how he is maximising profits - revenue per race yes, but not across the entire season.
I’m thinking your point about price is to Bolt’s benefit. If there are less options, he may have a chance to recover- if he runs everywhere, it couldn’t happen.